Cyld is a known tumour suppressor [18] and it is thought to act at the level of adaptor molecules such as TRAFs (TNF receptor-associated factor) and the IKK complex itself, namely on IKKγ ubiquitination [18]. Here, CYLD is linked to neoplasm.